These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 16361609)
1. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy. Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy. Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121 [TBL] [Abstract][Full Text] [Related]
3. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435 [TBL] [Abstract][Full Text] [Related]
4. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test. Névoret ML; Vinik AI J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645 [TBL] [Abstract][Full Text] [Related]
5. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS; Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854 [TBL] [Abstract][Full Text] [Related]
6. Treatment response in patients with clinical and supportive laboratory features of chronic inflammatory demyelinating polyneuropathy without demyelinative findings on nerve conduction studies: A retrospective study. Curry P; Herrmann DN; Stanton M; Mongiovi P; Akmyradov C; Logigian E Muscle Nerve; 2024 Nov; 70(5):1082-1088. PubMed ID: 38958279 [TBL] [Abstract][Full Text] [Related]
8. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182 [TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study. Echaniz-Laguna A; de Séze J; Chanson JB J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230 [TBL] [Abstract][Full Text] [Related]
10. [Importance of the nerve biopsy for the diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuritis: 8 cases]. Vallat JM; Tabaraud F; Magy L; Couratier P Bull Acad Natl Med; 2003; 187(2):387-99; discussion 399-403. PubMed ID: 14556448 [TBL] [Abstract][Full Text] [Related]
11. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases. Kuwabara S; Misawa S; Mori M; Tamura N; Kubota M; Hattori T J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):66-70. PubMed ID: 16361595 [TBL] [Abstract][Full Text] [Related]
12. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin. Cirillo G; Todisco V; Tedeschi G Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of intravenous immunoglobulin in CIDP. Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689 [TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Silwal A; Pitt M; Phadke R; Mankad K; Davison JE; Rossor A; DeVile C; Reilly MM; Manzur AY; Muntoni F; Munot P Neuromuscul Disord; 2018 Sep; 28(9):757-765. PubMed ID: 30072201 [TBL] [Abstract][Full Text] [Related]
15. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial. Bril V; Hadden RDM; Brannagan TH; Bar M; Chroni E; Rejdak K; Rivero A; Andersen H; Latov N; Levine T; Pasnoor M; Sacconi S; Souayah N; Anderson-Smits C; Duff K; Greco E; Hasan S; Li Z; Yel L; Ay H J Peripher Nerv Syst; 2023 Sep; 28(3):436-449. PubMed ID: 37314318 [TBL] [Abstract][Full Text] [Related]
18. Childhood CIDP: Study of 31 patients and comparison between slow and rapid-onset groups. Cabasson S; Tardieu M; Meunier A; Rouanet-Larriviere MF; Boulay C; Pedespan JM Brain Dev; 2015 Nov; 37(10):943-51. PubMed ID: 25921353 [TBL] [Abstract][Full Text] [Related]
19. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment. Pegat A; Boisseau W; Maisonobe T; Debs R; Lenglet T; Psimaras D; Azoulay-Cayla A; Fournier E; Viala K J Peripher Nerv Syst; 2020 Jun; 25(2):162-170. PubMed ID: 32364302 [TBL] [Abstract][Full Text] [Related]
20. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Cornblath DR; Hartung HP; Katzberg HD; Merkies ISJ; van Doorn PA J Peripher Nerv Syst; 2018 Jun; 23(2):108-114. PubMed ID: 29603842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]